Bright Minds Biosciences Inc (DRUG) — Defensive Interval Ratio

Latest as of March 2026: 125 days

Bright Minds Biosciences Inc (DRUG) has a Defensive Interval Ratio of 125 days as of March 2026. Defensive assets of $1.31 Million (cash $-, short-term investments $172.38K, receivables $1.14 Million) cover 125 days of daily cash needs of $10.49K/day. For the complete balance sheet picture, see DRUG current and non-current assets.

Defensive Interval Ratio

125 days
Days of operational coverage

Defensive Assets

$1.31 Million
Cash + ST Investments + Receivables

Daily Cash Need

$10.49K
Current Liabilities ÷ 365

Current Liabilities

$3.83 Million
USD

Bright Minds Biosciences Inc Defensive Interval Ratio (2021–2025)

This chart shows how Bright Minds Biosciences Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 125 days, meaning defensive assets of $1.31 Million can fund 125 days of operations without new revenue. Check Bright Minds Biosciences Inc (DRUG) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Annual Defensive Interval Ratio for Bright Minds Biosciences Inc (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for Bright Minds Biosciences Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 74 days $475.00K $6.40K/day $- $61.93K ▲ +40 days
2024 35 days $50.22K $1.45K/day $- $- ▼ -125 days
2023 160 days $123.23K $769.47/day $- $86.25K ▲ +100 days
2022 60 days $242.03K $4.03K/day $- $86.25K ▼ -52 days
2021 112 days $196.40K $1.75K/day $- $86.25K
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)